Annual revenue growth at Amgen (NASDAQ:AMGN) has faltered over the past few years as competition and lower prices have hurt sales of older products.Revenue at Nike (NYSE:NKE) has been steadily climbing since 2012, but the company's efforts over the past two years on its online platform and direct sales to customers are why I favor it today.